U.S. markets open in 2 hours 42 minutes
  • S&P Futures

    3,424.50
    -8.00 (-0.23%)
     
  • Dow Futures

    28,068.00
    -66.00 (-0.23%)
     
  • Nasdaq Futures

    11,670.00
    -21.25 (-0.18%)
     
  • Russell 2000 Futures

    1,603.90
    +0.80 (+0.05%)
     
  • Crude Oil

    40.23
    +0.20 (+0.50%)
     
  • Gold

    1,920.90
    -8.60 (-0.45%)
     
  • Silver

    25.01
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1837
    -0.0029 (-0.25%)
     
  • 10-Yr Bond

    0.8160
    0.0000 (0.00%)
     
  • Vix

    29.25
    -0.10 (-0.34%)
     
  • GBP/USD

    1.3109
    -0.0035 (-0.26%)
     
  • USD/JPY

    104.6800
    +0.1200 (+0.11%)
     
  • BTC-USD

    12,958.06
    +1,901.05 (+17.19%)
     
  • CMC Crypto 200

    260.55
    +15.66 (+6.39%)
     
  • FTSE 100

    5,766.05
    -10.45 (-0.18%)
     
  • Nikkei 225

    23,474.27
    -165.19 (-0.70%)
     

Nevada's prohibition of Quidel, Becton Dickinson's COVID-19 tests violates law - HHS official

·1 min read

Oct 9 (Reuters) - U.S. state of Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's (BD) Veritor point of care antigen tests in long-term care facilities violates federal law, a U.S. government official said on Friday.

"The letter (on ban) from Nevada officials can only be interpreted as reflecting a fundamental lack of basic knowledge about testing and interpreting results," said Admiral Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services, in a press briefing. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)